Submitted by Anonymous (not verified) on 27 October 2026 - 16:32
Human medicines European public assessment report (EPAR): Idacio, adalimumab, Date of authorisation: 02/04/2019, Revision: 17, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Idacio, adalimumab, Date of authorisation: 02/04/2019, Revision: 17, Status: Authorised